成人鼻窦道恶性肿瘤的当代管理
鼻窦道恶性肿瘤占头颈部肿瘤不足5%,发病率为每10万人0.5-1.0例,预后较差。本综述旨在描述鼻窦道恶性肿瘤的发病率、病因、表现、诊断、治疗及最新进展,涵盖鼻窦未分化癌、腺癌、鳞状细胞癌、嗅神经母细胞瘤、原发黏膜黑色素瘤、NUT癌及结外NK/T细胞淋巴瘤,并排除肉瘤及可归类为涎腺肿瘤的恶性肿瘤。
要点
- 鼻窦道恶性肿瘤罕见,占头颈部肿瘤不足5%,发病率每10万人0.5-1.0例。
- 综述涵盖鼻窦未分化癌、腺癌、鳞状细胞癌、嗅神经母细胞瘤等特有类型。
- 还包括原发黏膜黑色素瘤、NUT癌及结外NK/T细胞淋巴瘤;排除肉瘤和涎腺肿瘤。
核心结论
- 鼻窦道恶性肿瘤罕见且预后较差,而其他癌症的管理已取得显著进展。
- 本综述旨在描述鼻窦道恶性肿瘤的发病率、病因、表现、诊断、治疗及最新进展。
研究设计与样本
- 综述,检索范围未报告;未报告样本量。
主要发现
- 鼻窦道恶性肿瘤占所有头颈部肿瘤不足5%,发病率为每10万人0.5-1.0例。
关键数值与推荐
- 纳入诊断包括鼻窦未分化癌、鼻窦腺癌、鼻窦鳞状细胞癌和嗅神经母细胞瘤,这些为鼻窦道特有。
- 还涵盖鼻窦道可能遇到的原发黏膜黑色素瘤、NUT(睾丸核蛋白)癌和结外自然杀伤细胞/T细胞淋巴瘤。
- 为保持综述简洁聚焦,排除肉瘤及可归类为涎腺肿瘤的恶性肿瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sinonasal malignancies make up <5% of all head and neck neoplasms, with an incidence of 0.5-1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas significant progress has been made in the management of other cancers. The objective of the current review was to describe the incidence, causes, presentation, diagnosis, treatment, and recent developments of malignancies of the sinonasal tract. The diagnoses covered in this review included sinonasal undifferentiated carcinoma, sinonasal adenocarcinoma, sinonasal squamous cell carcinoma, and esthesioneuroblastoma, which are exclusive to the sinonasal tract. In addition, the authors covered malignances that are likely to be encountered in the sinonasal tract-primary mucosal melanoma, NUT (nuclear protein of the testis) carcinoma, and extranodal natural killer cell/T-cell lymphoma. For the purpose of keeping this review as concise and focused as possible, sarcomas and malignancies that can be classified as salivary gland neoplasms were excluded.
引用
- Thawani R, Kim MS, Arastu A, et al. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin. 2022. PMID: 35916666. doi:10.3322/caac.21752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。